Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jon E Sprague

Showing results (41-50 of 91) with videos related to

Pageof 10
Sort By:
Behavioural Pharmacology|March 12, 2008
Influence of thyroid hormones on 3,4-methylenedioxymethamphetamine-induced thermogenesis and reinforcing strength in monkeysMatthew L Banks, Paul W Czoty, Jon E Sprague, et al.
The International Journal on Drug Policy|February 8, 2022
COVID-19 economic impact payments and opioid overdose deathsJon E Sprague, Arthur B Yeh, Qizhen Lan, et al.
Neuroscience Letters|March 23, 2024
Effects of the designer drug 4-methylamphetamine on core temperature and serotonin levels in the striatum and hippocampus of ratsT Lee Gilman, Jeremy R Canfield, Travis J Worst, et al.
Chemical Biology & Drug Design|February 6, 2019
A high-quality homology model for the human dopamine transporter validated for drug design purposesMatthew C Castellana, Andrea Castellar Montes, Jon E Sprague, et al.
Pharmacogenomics|August 23, 2021
Systematic review of Pharmacogenomics Knowledgebase evidence for pharmacogenomic links to the dopamine reward pathway for heroin dependenceMaggie L McCorkle, David F Kisor, Caroline E Freiermuth, et al.
Pharmacology, Biochemistry, and Behavior|August 15, 2002
An antisense oligonucleotide targeted at MAO-B attenuates rat striatal serotonergic neurotoxicity induced by MDMAErin M Falk, Valerie J Cook, David E Nichols, et al.
Anesthesiology|June 29, 2004
Dantrolene use in 3,4-methylenedioxymethamphetamine (ecstasy)-mediated hyperthermiaDaniel E Rusyniak, Matthew L Banks, Edward M Mills, et al.
Synapse (New York, N.Y.)|January 20, 2006
Hypothyroidism alters striatal dopamine release mediated by 3,4-methylenedioxymethamphetamine (MDMA, ecstasy)Andrea L Peterson, Tracy L Gilman, Matthew L Banks, et al.
The Journal of Emergency Medicine|August 17, 2015
The α- and β-Adrenergic Antagonist Controversy with Sympathomimetic AgentsMatthew L Banks, Travis J Worst, Daniel E Rusyniak, et al.
European Journal of Pharmacology|March 7, 2023
Influence of adrenalectomy on the gut microbiome and MDMA-induced hyperthermiaAmal Aburahma, Srishti Rana, Ray Larsen, et al.
Pageof 10

Showing results (41-50 of 91) with videos related to

Sort By:
Pageof 10
Behavioural Pharmacology|March 12, 2008
Influence of thyroid hormones on 3,4-methylenedioxymethamphetamine-induced thermogenesis and reinforcing strength in monkeysMatthew L Banks, Paul W Czoty, Jon E Sprague, et al.
The International Journal on Drug Policy|February 8, 2022
COVID-19 economic impact payments and opioid overdose deathsJon E Sprague, Arthur B Yeh, Qizhen Lan, et al.
Neuroscience Letters|March 23, 2024
Effects of the designer drug 4-methylamphetamine on core temperature and serotonin levels in the striatum and hippocampus of ratsT Lee Gilman, Jeremy R Canfield, Travis J Worst, et al.
Chemical Biology & Drug Design|February 6, 2019
A high-quality homology model for the human dopamine transporter validated for drug design purposesMatthew C Castellana, Andrea Castellar Montes, Jon E Sprague, et al.
Pharmacogenomics|August 23, 2021
Systematic review of Pharmacogenomics Knowledgebase evidence for pharmacogenomic links to the dopamine reward pathway for heroin dependenceMaggie L McCorkle, David F Kisor, Caroline E Freiermuth, et al.
Pharmacology, Biochemistry, and Behavior|August 15, 2002
An antisense oligonucleotide targeted at MAO-B attenuates rat striatal serotonergic neurotoxicity induced by MDMAErin M Falk, Valerie J Cook, David E Nichols, et al.
Anesthesiology|June 29, 2004
Dantrolene use in 3,4-methylenedioxymethamphetamine (ecstasy)-mediated hyperthermiaDaniel E Rusyniak, Matthew L Banks, Edward M Mills, et al.
Synapse (New York, N.Y.)|January 20, 2006
Hypothyroidism alters striatal dopamine release mediated by 3,4-methylenedioxymethamphetamine (MDMA, ecstasy)Andrea L Peterson, Tracy L Gilman, Matthew L Banks, et al.
The Journal of Emergency Medicine|August 17, 2015
The α- and β-Adrenergic Antagonist Controversy with Sympathomimetic AgentsMatthew L Banks, Travis J Worst, Daniel E Rusyniak, et al.
European Journal of Pharmacology|March 7, 2023
Influence of adrenalectomy on the gut microbiome and MDMA-induced hyperthermiaAmal Aburahma, Srishti Rana, Ray Larsen, et al.
Pageof 10